SCHEMBL703695

SCHEMBL703695

[Sn]C(C=C(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 3/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
CYP2D6 P10635 3/20 0.37
ESR1 P03372 1/20 0.36
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP19A1 P11511 2/20 0.35
CYP11B2 P19099 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MCOLN3 Q8TDD5 1/20 0.35
TRPA1 O75762 1/20 0.33
SRC P12931 1/20 0.33
TSHR P16473 2/20 0.32
CHRM2 P08172 1/20 0.32
ADRA1A P35348 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1794030 0.77 L3MBTL1 (0.41) TDP1L3MBTL1LMNACES2CES1
SCHEMBL10613825 0.77 L3MBTL1 (0.41) TDP1L3MBTL1LMNACES2CES1
SCHEMBL11133995 0.74 TDP1 (0.39) TDP1L3MBTL1LMNACES2CES1
SCHEMBL5171010 0.74 L3MBTL1 (0.39) TDP1L3MBTL1LMNACES2CES1
SCHEMBL5967505 0.74 DPP4 (0.42) TDP1L3MBTL1LMNACES2CES1
SCHEMBL9806391 0.74 TRPA1 (0.55) TDP1L3MBTL1LMNACYP2D6CYP2C9
Hydrochloric Acid SCHEMBL3838251 0.72 TDP1 (0.38) TDP1L3MBTL1LMNACES2CES1
Hydrochloric Acid SCHEMBL2996840 0.72 L3MBTL1 (0.38) TDP1L3MBTL1LMNACES2CES1
Hydrochloric Acid SCHEMBL3845154 0.72 DPP4 (0.41) TDP1L3MBTL1LMNACES2CES1
Bromide SCHEMBL3005581 0.72 L3MBTL1 (0.38) TDP1L3MBTL1LMNACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124273-B2 Nonaqueous electrolyte solution and lithium secondary battery using same UBE INDUSTRIES, LTD. (JP) 2012-02-28 US claimed
US-20090280404-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME UBE INDUSTRIES LTD (JP) 2009-11-12 US claimed
US-20150080581-A1 MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS RIMTEC CORPORATION (JP) 2015-03-19 US disclosed
US-8927670-B2 Multicoordinated metal complexes for use in metathesis reactions RIMTEC CORPORATION (JP) 2015-01-06 US disclosed
EP-2397475-B1 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same IMEC (BE) 2014-11-12 EP disclosed
US-8765882-B2 Polythiophene based active layer for solar cells IMEC (BE) 2014-07-01 US disclosed
US-8450604-B2 Polymerisable compounds for making opto-electronic devices IMEC (BE) 2013-05-28 US disclosed
US-8329923-B2 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same IMEC (BE) 2012-12-11 US disclosed
US-20120279569-A1 POLYTHIOPHENE BASED ACTIVE LAYER FOR SOLAR CELLS UNIVERSITEIT HASSELT (BE) 2012-11-08 US disclosed
EP-2509972-A1 POLYMERS COMPRISING 3 -SUBSTITUTED THIOPHENE MOIETIES AS ACTIVE LAYERS FOR SOLAR CELLS IMEC (BE) 2012-10-17 EP disclosed
EP-2307398-B1 POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES IMEC (BE) 2012-09-05 EP disclosed
US-20070043188-A1 MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS TELENE S.A.S. (FR) 2007-02-22 US disclosed
US-6872493-B2 Nonaqueous electrolytic solution and nonaqueous secondary battery DENSO CORPORATION (JP) 2005-03-29 US disclosed
US-6624116-B1 Co-feeding a volatile Group 8B metal compound and/or a volatile promoter compound with the paraffinic hydrocarbon and oxygen feedstream into the oxidation reactor under ignition or autothermal process conditions DOW GLOBAL TECHNOLOGIES INC. 2003-09-23 US disclosed
EP-1114013-B1 ON-LINE SYNTHESIS AND REGENERATION OF A CATALYST USED IN AUTOTHERMAL OXIDATION DOW CHEMICAL CO (US) 2002-11-27 EP disclosed
US-20020076619-A1 Nonaqueous electrolytic solution and nonaqueous secondary battery ADEKA CORPORATION (JP) 2002-06-20 US disclosed
EP-1202373-A2 Nonaqueous electrolytic solution and nonaqueous secondary battery DENSO CORPORATION (JP) 2002-05-02 EP disclosed
EP-1114013-A1 ON-LINE SYNTHESIS AND REGENERATION OF A CATALYST USED IN AUTOTHERMAL OXIDATION THE DOW CHEMICAL COMPANY (US) 2001-07-11 EP disclosed
US-6166283-A On-line synthesis and regenerating of a catalyst used in autothermal oxidation THE DOW CHEMICAL COMPANY (US) 2000-12-26 US disclosed
WO-2000014037-A1 ON-LINE SYNTHESIS AND REGENERATION OF A CATALYST USED IN AUTOTHERMAL OXIDATION THE DOW CHEMICAL COMPANY (US) 2000-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080581-A1 MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS APEX1, SOD1, AP1M1 TDP1 3626/4885L3MBTL1 1916/4885LMNA 4135/4885
US-20120279569-A1 POLYTHIOPHENE BASED ACTIVE LAYER FOR SOLAR CELLS SCO2, CLTB, CLTC TDP1 4441/4885L3MBTL1 727/4885LMNA 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.